Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-039908
Filing Date
2025-05-06
Accepted
2025-05-06 08:32:06
Documents
61
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0239390-10q_cormedix.htm   iXBRL 10-Q 605728
2 CERTIFICATION ea023939001ex31-1_cormedix.htm EX-31.1 10470
3 CERTIFICATION ea023939001ex31-2_cormedix.htm EX-31.2 10002
4 CERTIFICATION ea023939001ex32-1_cormedix.htm EX-32.1 4276
5 CERTIFICATION ea023939001ex32-2_cormedix.htm EX-32.2 4414
  Complete submission text file 0001213900-25-039908.txt   4813013

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crmd-20250331.xsd EX-101.SCH 40663
7 XBRL CALCULATION FILE crmd-20250331_cal.xml EX-101.CAL 41912
8 XBRL DEFINITION FILE crmd-20250331_def.xml EX-101.DEF 213529
9 XBRL LABEL FILE crmd-20250331_lab.xml EX-101.LAB 411337
10 XBRL PRESENTATION FILE crmd-20250331_pre.xml EX-101.PRE 231182
63 EXTRACTED XBRL INSTANCE DOCUMENT ea0239390-10q_cormedix_htm.xml XML 558095
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34673 | Film No.: 25915390
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)